Omalizumab, sold under the brand name Xolair among others, is an injectable medication to treat severe persistent allergic forms of asthma, nasal polyps, urticaria, and immunoglobulin E-mediated food allergy. From Wikipedia
The drug omalizumab, known as Xolair, significantly reduces severe allergic reactions in children, offering a new layer of protection against food allergens.
